NCT06827340View on ClinicalTrials.gov

Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

January 1, 1995

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Prostate Cancer (Adenocarcinoma)
Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06827340 - Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter